Tanvir Walele

Imperial Brands (United Kingdom)

Papers

1

Total Citations

85

H-Index

1

About

Dr. Tanvir Walele is a leading researcher in the field of tobacco harm reduction and respiratory toxicology, with a primary focus on evaluating the comparative safety profiles of conventional cigarettes and next-generation nicotine products. His most cited work, a 2019 study employing a 3D in vitro human respiratory model, has garnered 85 citations and represents a pivotal contribution to the field. This research directly addresses the urgent need for robust, non-animal testing methods to assess the toxicological impact of e-cigarette aerosols versus cigarette smoke. By pioneering the use of advanced in vitro systems, Dr. Walele has helped establish a scientific framework for understanding how switching to e-cigarettes may reduce respiratory harm. His work is instrumental in supporting the "3Rs" principles—Replace, Reduce, and Refine—in animal testing, offering a more ethical and human-relevant approach to safety assessment. Through these contributions, Dr. Walele has become a key voice in the ongoing global conversation about tobacco harm reduction, providing critical data that informs both regulatory decisions and public health strategies.

Research Focus

Key Achievements

1
H-Index
1
Papers
85
Total Citations
85
Avg Citations/Paper
🏆 Most Cited Paper
Toxicological comparison of cigarette smoke and e-cigarette aerosol using a 3D in vitro human respiratory model
85 citations · 2019
📈 Most Prolific Year: 2019 (1 Papers)
🤝 Key Collaborators: 5
🏛 Institutions: Imperial Brands (United Kingdom)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago